Absci Corp. (ABSI)
2.96
-0.20
(-6.33%)
USD |
NASDAQ |
Jan 23, 13:44
Absci Cash from Investing (Quarterly): -63.70M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| CorMedix, Inc. | -291.32M |
| Verastem, Inc. | -8.279M |
| Fortress Biotech, Inc. | 2.87M |
| Anavex Life Sciences Corp. | 0.00 |
| Ocugen, Inc. | -0.086M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -25.03M |
| Cash from Financing (Quarterly) | 60.32M |
| Free Cash Flow | -81.94M |
| Free Cash Flow Per Share (Quarterly) | -0.1808 |
| Free Cash Flow to Equity (Quarterly) | -24.80M |
| Free Cash Flow to Firm (Quarterly) | -25.95M |
| Free Cash Flow Yield | -21.70% |